| Helicobacter pylori strain-specific blood biomarker and lung cancer risk |
Qiuyin Cai |
Vanderbilt University Medical Center |
PLCO |
Jan 10, 2020 |
2019-1026 |
| Vegetarianism and chronic disease risk |
Yumie Takata |
Oregon State University |
PLCO |
Jan 8, 2020 |
PLCO-564 |
| Mutational landscape of in situ breast cancers in relation to invasive breast cancers |
Clara Bodelon |
NIH |
PLCO |
Dec 27, 2019 |
2019-1017 |
| A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and ovarian and endometrial cancers in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Dec 27, 2019 |
2019-1010 |
| Associations of Serum Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Colorectal Cancer Risk |
Doratha Byrd |
Moffitt Cancer Center |
PLCO |
Dec 27, 2019 |
2019-1004 |
| Instrumental variable methods in survival outcome |
Youjin Lee |
University of Pennsylvania |
PLCO |
Dec 16, 2019 |
PLCO-561 |
| Blood metabolomics, smoking and lung cancer risk |
Wei Jie Seow |
National University of Singapore |
PLCO |
Dec 16, 2019 |
PLCO-558 |
| Analyses using GWAS data from PLCO to evaluate genetic impact on colorectal screening and outcomes |
Wen-Yi Huang |
National Cancer Institute |
PLCO |
Dec 11, 2019 |
PLCO-560 |
| Integrating Genomics and Metabolomics to Develop Predictive Models of Prostate Cancer in Multiethnic Men |
Burcu Darst |
University of Southern California |
PLCO |
Nov 26, 2019 |
PLCO-555 |
| Associations of Dietary Inflammatory and Insulinemic Potential with Risk of Cancer Development |
Fred Tabung |
The Ohio State University College of Medicine |
PLCO |
Nov 25, 2019 |
PLCO-553 |
| Association of endogenous estrogens, estrogen metabolites, androgens and androgen metabolites with Ovarian Cancer |
Britton Trabert |
NIH |
PLCO |
Nov 21, 2019 |
2016-0047 |
| Machine Learning Application of Cancer Data Analysis |
Mochen Li |
Purdue University |
PLCO |
Nov 13, 2019 |
PLCO-552 |
| Incorporating Biomarkers to Improve Lung Cancer Risk Prediction |
Samir Hanash |
University of Texas at MD Anderson |
PLCO |
Nov 4, 2019 |
PLCO-549 |
| Machine Learning to select patients benefiting from prostate cancer screening |
Jean-Emmanuel Bibault |
Laboratory of Artificial Intelligence in Medicine and Biomedical Physics, Stanford University |
PLCO |
Oct 24, 2019 |
PLCO-541 |
| Predicting Cancer diagnosis based on preliminary screenings |
Jonathan Mendoza |
Independent |
PLCO |
Oct 24, 2019 |
PLCO-532 |
| Evaluation of Patients Data using AI techniques and It's Application in Pancreatic Cancer Differential Diagnosis |
Wanessa Sena |
Federal Institute of Pernambuco |
PLCO |
Oct 10, 2019 |
PLCO-539 |
| Link-based survival additive models with mixed types of censoring. |
Giampiero Marra |
University College London |
PLCO |
Oct 8, 2019 |
PLCO-538 |
| “Development of a probabilistic network for clinical pathways based on patient cohort characteristics, outcome-indicators and clinical workflow analysis to create artificial patients with prostatic adenocarcinoma” |
Andrea Riedel |
Institute for general practitioners |
PLCO |
Oct 8, 2019 |
PLCO-535 |
| Tobacco smoking is associated with increased tumor grade and stage and grade along with the mucinous carcinoma histopathologic type. |
Rodger Rothenberger |
University of Cincinnati |
PLCO |
Oct 3, 2019 |
PLCO-534 |
| A Comparison Between Multi Classification Algorithms on PLCO Colorectal Cancer Dataset |
Bawer Berwary |
Van Yuzuncu Yil University |
PLCO |
Oct 3, 2019 |
PLCO-533 |
